跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
Authorized
STANDARD
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
formative pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
52e248f9e37cf83b
Company
formative pharma inc.
Type
Standard
Approval Details
Approval Id
52e248f9e37cf83b
Drug Approval Canada Name
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
Product Name
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
Status
Marketed
Status Date
2024-03-19
Original Market Date
2024-03-19
Din
02536714
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intraspinal
Schedule
Ethical
Ahfs
72:00.00
Atc Original
N01BB01 BUPIVACAINE
Atc Name
n 01 bb 01
Aig Number
0108896002
Company Name
formative pharma inc.
Company Address
200, 4145 North Service Road, Burlington, Ontario, Canada, L7L 6A3
Active Ingredients
BUPIVACAINE HYDROCHLORIDE
7.5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
52e248f9e37cf83b
Type
Standard
Back to Health Canada Approvals
